Stay updated on Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial

Sign up to get notified when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The latest version adds updates to the study status and recruitment status in the record history, reflecting changes in the trial's progression. There are no evident additions of new documents or locations in the latest update.
    Difference
    0.1%
    Check dated 2025-11-03T01:07:18.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Major change: updated operating-status notice and new version v3.2.0; removed old version v3.1.0.
    Difference
    11%
    Check dated 2025-10-05T10:08:08.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a. No changes to core content, pricing, or stock are evident.
    Difference
    0.3%
    Check dated 2025-09-28T03:13:55.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2, and the Back to Top control was removed. No substantive changes to core content or key information were detected.
    Difference
    0.6%
    Check dated 2025-09-13T17:35:11.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.7%
    Check dated 2025-09-06T14:58:48.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The web page has added a facility name and location details while removing specific state, country, and city information. This indicates a shift towards a more generalized presentation of location data.
    Difference
    25%
    Check dated 2025-08-30T11:46:12.000Z thumbnail image

Stay in the know with updates to Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efpeglenatide vs Placebo in T2DM with Basal Insulin: Clinical Trial page.